Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Peptide Antibiotics Market Report 2024

Peptide Antibiotics Global Market Report 2025 – By Type (Ribosomal Synthesized Peptide Antibiotics, Non-ribosomal Synthesized Peptide Antibiotics), By Drugs (Daptomycin, Dalbavancin, Telavancin, Other Drugs), By Disease Outlook (Skin Infection, HABP/VABP, Blood Stream Infection, Other Diseases), By Distribution Channel (Hospitals, Homecare, Specialty Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

Peptide Antibiotics Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Peptide Antibiotics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Peptide Antibiotics Market Definition

Peptide antibiotics refer to antibiotics made up of peptides the physical rupture of cell membranes underpins the antibacterial activity. The peptide antibiotics are used to permeate bacterial membranes, collect within bacteria, and then interfere with bacterial functioning.

The main types of peptide antibiotics are ribosomal synthesized peptide antibiotics and non-ribosomal synthesized peptide antibiotics. The ribosomal synthesized peptide antibiotics destroy or modify the drug, change the drug target, decrease or raise drug uptake, and substitute a different metabolic step as the medication's target. Ribosomal synthesized peptide antibiotics refer to antimicrobial peptides generated by ribosomes and produced by practically all species, from bacteria to plants and animals. The various drugs under peptide antibiotics are daptomycin, dalbavancin, telavancin, and other drugs used to treat several diseases such as skin infection, HABP/VABP, blood stream infection, and other diseases. The peptide antibiotics are used and distributed through hospitals, homecare, specialty clinics, and other distribution channels.

Peptide Antibiotics Market Segmentation

The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics

2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases

4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:

1) By Ribosomal Synthesized Peptide Antibiotics: aminoglycosides, Macrolides, Tetracyclines, Lincosamides

2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, vancomycin, Polymyxins, Cyclic Lipopeptides

Peptide Antibiotics Market Size and growth rate 2025 to 2029: Graph

Peptide Antibiotics Market Size 2025 And Growth Rate

The peptide antibiotics market size has grown rapidly in recent years. It will grow from $5.25 billion in 2024 to $5.82 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to discovery and development of peptide antibiotics, increased antibiotic resistance, rise inThe incidence of infectious diseases, advances in peptide synthesis technologies, growth ofThe pharmaceutical industry.

Peptide Antibiotics Market Growth Forecast

The peptide antibiotics market size is expected to see strong growth in the next few years. It will grow to $8.47 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to emphasis on novel antibiotics development, increasing global incidence of antibiotic-resistant infections, expansion of research and development in antimicrobial peptides, regulatory support for new antibiotic approvals. Major trends in the forecast period include exploration of natural sources for antimicrobial peptides, application of peptide antibiotics in animal health, focus on peptide engineering for enhanced efficacy, development of combination peptide antibiotics, integration of AI and machine learning in peptide antibiotic discovery.

Book your 30 minutes free consultation with our research experts

Contact Us

Peptide Antibiotics Market Driver: Rising Prevalence Of Infectious Diseases Fuels Peptide Antibiotics Market

The increase in the prevalence of various infectious diseases is expected to propel the growth of the peptide antibiotics market. Infectious diseases are illnesses caused by harmful micro-organisms such as bacteria, fungi, parasites, and others. The major reasons for the rise in infectious diseases are rapid urbanization, climate change, increasing risk of disease emergence, and others, which have increased the demand for peptide antibiotics. Peptide antibiotics physically rupture the cell membranes and underpin the antibacterial activity. For instance, in May 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, in the America region, dengue cases had already surpassed seven million by April 2024, which is much higher than the 4.6 million cases reported in all of 2023. Therefore, the increase in the incidence of infectious is driving the peptide antibiotics market growth.

Peptide Antibiotics Market Driver: Rising Incidence Of Chronic Diseases Boosts Peptide Antibiotics Market

An increase in the incidence of chronic diseases is expected to drive the peptide antibiotics market. Chronic diseases are illnesses that last a year or longer, demand ongoing medical attention, and limit daily activities. Chronic diseases are on the rise as a result of increased tobacco use, poor nutrition, physical inactivity, excessive alcohol consumption, and other factors. Peptide antibiotics are used to treat chronic diseases by administering the drug in the target area. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of chronic conditions is fueling the growth of the peptide antibiotics market.

Global Peptide Antibiotics Market Major Players

Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG

Global Peptide Antibiotics Market Trend: Strategic Partnerships Is A Key Trend Driving Growth In The Peptide Antibiotics Market

The strategic partnership is a key trend gaining popularity in the peptide antibiotics market. Major companies operating in the peptide antibiotics market are entering into partnerships to expand their market and leverage each other's resources. For instance, in January 2022, Berkeley Lights, a US-based digital cell biology company, partnered with Aanika Biosciences. In this partnership, Aanika will leverage Berkeley Lights' high-throughput, functional screening service to swiftly find and refine functional antimicrobial peptides (AMPs) capable of eliminating dangerous bacteria, particularly those that cause foodborne disease outbreaks. Furthermore, the Beacon Optofluidic Platform will be used to identify peptides that are harmful to bacteria in order to develop a novel antibacterial tag, which will then be used in their bacterial spore-based barcoding technology to secure the food supply chain. Aanika Biosciences is a US-based biotechnology company.

Global Peptide Antibiotics Market Trend: Generic Versions To Provide An Affordable Alternative To Patients

Major companies operating in the peptide antibiotics market are launching generic versions to provide an affordable alternative to patients. Generic versions of peptide antibiotics are cost-effective, off-patent alternatives to brand-name peptide-based antibiotics, used to treat various bacterial infections. For instance, in July 2023, Camber Pharmaceuticals, a US-based pharmaceutical company, expanded its portfolio with the launch of a generic version of Daptomycin for Injection. Daptomycin for Injection is a kind of peptide antibiotic. It is a cyclic lipopeptide antibiotic that is synthesized by a non-ribosomal machinery. The generic version is available in both 350 mg and 500 mg strengths and is prescribed for the treatment of complicated skin and skin structure infections (cSSSI) in adult patients and pediatric patients aged 1 to 17 years.

Regional Outlook For The Global Peptide Antibiotics Market

North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the peptide antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

What Defines the Peptide Antibiotics Market?

The peptide antibiotics market consists of sales of oral, intravenous, intramuscular and topical peptide antibiotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Peptide Antibiotics Industry?

The peptide antibiotics market research report is one of a series of new reports from The Business Research Company that provides peptide antibiotics market statistics, including peptide antibiotics industry global market size, regional shares, competitors with a peptide antibiotics market share, detailed peptide antibiotics market segments, market trends and opportunities, and any further data you may need to thrive in the peptide antibiotics industry. This peptide antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Peptide Antibiotics Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $5.82 billion
Revenue Forecast In 2034 $8.47 billion
Growth Rate CAGR of 9.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels Subsegments: 1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Peptide Antibiotics Market Characteristics

    3. Peptide Antibiotics Market Trends And Strategies

    4. Peptide Antibiotics Market- Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Peptide Antibiotics Growth Analysis And Strategic Analysis Framework

    5.1. Global Peptide Antibiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Peptide Antibiotics Market Growth Rate Analysis

    5.4. Global Peptide Antibiotics Historic Market Size and Growth, 2019- 2024, Value ($ Billion)

    5.5. Global Peptide Antibiotics Forecast Market Size and Growth, 2024- 2029, 2034F, Value ($ Billion)

    5.6. Global Peptide Antibiotics Total Addressable Market (TAM)

    6. Peptide Antibiotics Market Segmentation

    6.1. Global Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Ribosomal Synthesized Peptide Antibiotics

    Non-rRibosomal Synthesized Peptide Antibiotics

    6.2. Global Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Daptomycin

    Dalbavancin

    Telavancin

    Other Drugs

    6.3. Global Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Skin Infection

    HABP/VABP

    Blood Stream Infection

    Other Diseases

    6.4. Global Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Homecare

    Specialty Clinics

    Other Distribution Channels

    6.5. Global Peptide Antibiotics Market, Sub-Segmentation Of Ribosomal Synthesized Peptide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Aminoglycosides

    Macrolides

    Tetracyclines

    Lincosamides

    6.6. Global Peptide Antibiotics Market, Sub-Segmentation Of Non-Ribosomal Synthesized Peptide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Bacitracins

    Vancomycin

    Polymyxins

    Cyclic Lipopeptides

    7. Peptide Antibiotics Market Regional And Country Analysis

    7.1. Global Peptide Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Peptide Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Peptide Antibiotics Market

    8.1. Asia-Pacific Peptide Antibiotics Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Peptide Antibiotics Market

    9.1. China Peptide Antibiotics Market Overview

    9.2. China Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Peptide Antibiotics Market

    10.1. India Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Peptide Antibiotics Market

    11.1. Japan Peptide Antibiotics Market Overview

    11.2. Japan Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Peptide Antibiotics Market

    12.1. Australia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Peptide Antibiotics Market

    13.1. Indonesia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Peptide Antibiotics Market

    14.1. South Korea Peptide Antibiotics Market Overview

    14.2. South Korea Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Peptide Antibiotics Market

    15.1. Western Europe Peptide Antibiotics Market Overview

    15.2. Western Europe Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Peptide Antibiotics Market

    16.1. UK Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Peptide Antibiotics Market

    17.1. Germany Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Peptide Antibiotics Market

    18.1. France Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Peptide Antibiotics Market

    19.1. Italy Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Peptide Antibiotics Market

    20.1. Spain Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Peptide Antibiotics Market

    21.1. Eastern Europe Peptide Antibiotics Market Overview

    21.2. Eastern Europe Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Peptide Antibiotics Market

    22.1. Russia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Peptide Antibiotics Market

    23.1. North America Peptide Antibiotics Market Overview

    23.2. North America Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Peptide Antibiotics Market

    24.1. USA Peptide Antibiotics Market Overview

    24.2. USA Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Peptide Antibiotics Market

    25.1. Canada Peptide Antibiotics Market Overview

    25.2. Canada Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Peptide Antibiotics Market

    26.1. South America Peptide Antibiotics Market Overview

    26.2. South America Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Peptide Antibiotics Market

    27.1. Brazil Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Peptide Antibiotics Market

    28.1. Middle East Peptide Antibiotics Market Overview

    28.2. Middle East Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Peptide Antibiotics Market

    29.1. Africa Peptide Antibiotics Market Overview

    29.2. Africa Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Peptide Antibiotics Market Competitive Landscape And Company Profiles

    30.1. Peptide Antibiotics Market Competitive Landscape

    30.2. Peptide Antibiotics Market Company Profiles

    30.2.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Peptide Antibiotics Market Other Major And Innovative Companies

    31.1. AbbVie Inc.

    31.2. Sandoz International GmbH

    31.3. Xellia APS

    31.4. Johnson & Johnson Inc.

    31.5. AstraZeneca PLC

    31.6. Bayer AG

    31.7. Bristol-Myers Squibb Company

    31.8. Lupin Pharmaceuticals Inc.

    31.9. Sun Pharmaceutical Industries Ltd.

    31.10. Teva Pharmaceutical Industries Ltd.

    31.11. Torrent Pharmaceuticals Ltd.

    31.12. Wockhardt Ltd.

    31.13. Zydus Lifesciences Limited

    31.14. Alkem Laboratories Limited

    31.15. Allecra Therapeutics GmbH

    32. Global Peptide Antibiotics Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Peptide Antibiotics Market

    34. Recent Developments In The Peptide Antibiotics Market

    35. Peptide Antibiotics Market High Potential Countries, Segments and Strategies

    35.1 Peptide Antibiotics Market In 2029- Countries Offering Most New Opportunities

    35.2 Peptide Antibiotics Market In 2029- Segments Offering Most New Opportunities

    35.3 Peptide Antibiotics Market In 2029- Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Peptide Antibiotics Market, Sub-Segmentation Of Ribosomal Synthesized Peptide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Peptide Antibiotics Market, Sub-Segmentation Of Non-Ribosomal Synthesized Peptide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Peptide Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Peptide Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Eli Lilly and Company Financial Performance
  • Table 78: GlaxoSmithKline plc Financial Performance
  • Table 79: Novartis AG Financial Performance
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: Merck & Co. Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Peptide Antibiotics Market, Sub-Segmentation Of Ribosomal Synthesized Peptide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Peptide Antibiotics Market, Sub-Segmentation Of Non-Ribosomal Synthesized Peptide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Peptide Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Peptide Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Eli Lilly and Company Financial Performance
  • Figure 78: GlaxoSmithKline plc Financial Performance
  • Figure 79: Novartis AG Financial Performance
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: Merck & Co. Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the regenerative medicine market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the gynecology drugs market research report 2022 with industry size, share, segments and market growth

Read More

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Nutritional Feed Additives Global Market Report 2025 – By Form (Dry, Liquid, Other Forms), By Additive Type (Antibiotics, Vitamins, Antioxidants, Amino Acids, Enzymes, Mycotoxin Detoxifiers, Prebiotics, Probiotics, Flavors And Sweeteners, Pigments, Binders, Minerals), By Livestock (Ruminants, Poultry, Swine, Aquatic), By Distribution Channel (Direct, Indirect, Hypermarket/Supermarket, Specialty Stores, Online Retail) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmacies and Drug Stores Global Market Report 2025 – By Drug Type (Prescription Drugs, OTC drugs), By Type (Community Pharmacy, Hospital Pharmacy, Clinical Pharmacy, Industrial Pharmacy, Compounding Pharmacy, Consulting Pharmacy, Ambulatory Care Pharmacy, Regulatory Pharmacy, Home Care Pharmacy), By Product Type (Skin Care, Cold and Flu, Dental, Weight Loss, Vitamins, Other Product Types) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Functional Foods Global Market Report 2025 – By Product Type (Bakery & Cereals, Dairy Products, Meat, Fish & Eggs, Soy Products, Fats & Oils, Other Product Types), By Ingredients (Carotenoids, Dietary Fibers, Fatty Acids, Minerals, Prebiotics & Probiotics, Vitamins, Other Ingredients), By Application (Sports Nutrition, Weight Management, Immunity, Digestive Health, Clinical Nutrition, Cardio Health, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Vitamin and Minerals Global Market Report 2025 – By Type (Multivitamin, Single Vitamin, Multi Mineral, Single Mineral), By Application (Energy And Weight Management, General Health, Bone And Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-Cancer, Other Applications), By Distribution Channel (Pharmacies And Drug Stores, Supermarkets And Hypermarkets, Online Channels), By End-User (Adults, Geriatric, Pregnant Women, Children, Infants) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anticoagulants Global Market Report 2025 – By Drug Class (Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes), By Route Of Administration (Oral Anticoagulant, Injectable Anticoagulant), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications), By End User (Hospitals, Homecare, Specialty Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Multivitamin Capsules And Tablets Global Market Report 2025 – By Type (Multivitamins Tablets, Multivitamins Capsules), By Distribution Channel (Store Based, Non-Store Based), By Application (Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-Cancer, Other Applications ), By End User (Adults, Geriatric, Pregnant Women, Children, Infants) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Food Encapsulation Global Market Report 2025 – By Technology (Micro Encapsulation, Nano Encapsulation, Hybrid Technology, Macro Encapsulation), By Shell Material (Polysaccharides, Proteins, Lipids, Emulsifiers, Other Shell Materials), By Core Phase (Minerals, Organic Acids, Vitamins, Enzymes, Probiotics, Additives, Essential Oils, Prebiotics, Other Substances,), By Application (Dietary Supplements, Functional Food Products, Bakery Products, Confectionery, Beverages, Dairy Products, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the peptide antibiotics market?

Peptide antibiotics refer to antibiotics made up of peptides the physical rupture of cell membranes underpins the antibacterial activity. The peptide antibiotics are used to permeate bacterial membranes, collect within bacteria, and then interfere with bacterial functioning. For further insights on the peptide antibiotics market, request a sample here

How will the peptide antibiotics market drivers and restraints affect the peptide antibiotics market dynamics? What forces will shape the peptide antibiotics industry going forward?

The peptide antibiotics market major growth driver - Rising Prevalence Of Infectious Diseases Fuels Peptide Antibiotics Market. For further insights on the peptide antibiotics market, request a sample here

What is the forecast market size or the forecast market value of the peptide antibiotics market?

The peptide antibiotics market size has grown rapidly in recent years. It will grow from $5.25 billion in 2024 to $5.82 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to discovery and development of peptide antibiotics, increased antibiotic resistance, rise inThe incidence of infectious diseases, advances in peptide synthesis technologies, growth ofThe pharmaceutical industry. The peptide antibiotics market size is expected to see strong growth in the next few years. It will grow to $8.47 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to emphasis on novel antibiotics development, increasing global incidence of antibiotic-resistant infections, expansion of research and development in antimicrobial peptides, regulatory support for new antibiotic approvals. Major trends in the forecast period include exploration of natural sources for antimicrobial peptides, application of peptide antibiotics in animal health, focus on peptide engineering for enhanced efficacy, development of combination peptide antibiotics, integration of ai and machine learning in peptide antibiotic discovery. For further insights on the peptide antibiotics market, request a sample here

How is the peptide antibiotics market segmented?

The peptide antibiotics market is segmented
1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic LipopeptidesFor further insights on the peptide antibiotics market, request a sample here

Which region has the largest share of the peptide antibiotics market? What are the other regions covered in the report?

North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the peptide antibiotics market, request a sample here.

Who are the major players in the peptide antibiotics market?

Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG For further insights on the peptide antibiotics market, request a sample here.

What are the key trends in the peptide antibiotics market?

Major trend in the peptide antibiotics market - Strategic Partnerships Is A Key Trend Driving Growth In The Peptide Antibiotics Market. For further insights on the peptide antibiotics market, request a sample here.

What are the major opportunities in the peptide antibiotics market? What are the strategies for the peptide antibiotics market?

For detailed insights on the major opportunities and strategies in the peptide antibiotics market, request a sample here.

How does the peptide antibiotics market relate to the overall economy and other similar markets?

For detailed insights on peptide antibiotics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the peptide antibiotics industry?

For detailed insights on the mergers and acquisitions in the peptide antibiotics industry, request a sample here.

What are the key dynamics influencing the peptide antibiotics market growth? SWOT analysis of the peptide antibiotics market.

For detailed insights on the key dynamics influencing the peptide antibiotics market growth and SWOT analysis of the peptide antibiotics industry, request a sample here.